Pfizer 2024 Revenues Outlook Falls Short, Shares Drop 7% to $26.50

Shares of Pfizer fell more than 7% to $26.50 on Wednesday after the company laid out an outlook for next year that missed estimates.

Revenues in 2024 are planned to be 60 billion. in the amount of dollars (with a shift of 1.5 billion dollars to one side or the other), which is less than 63.1 billion dollar estimates, reports Investing.com.

Pfizer expected revenues include approximately 8 bln. dollars from Covid-19 products – Comirnaty and Paxlovid – as well as approximately 3.1 billion. dollars from Seen.

Pfizer intend to complete Seen purchase on December 14.

Adjusted earnings per share are expected to be in the range of $2.05 to $2.25, significantly below the forecast of $3.16.

2023-12-13 12:41:26
#Pfizer #shares #fall #sharply #announcing #earnings #guidance